Phase II Study of Monosialotetrahexosylganglioside for Cerebral Radiation Necrosis
The necrotic mass shown on MRI must be measured in two dimensions. No local or regional
recurrence, no distant metastasis. Karnofsky performance status of at least 70 and were
supposed to live more than 6 months.
- CRN combined with local or regional relapse, or with distant metastasis. ② CRN
combined with other cerebrovascular disease. ③CRN combined with the second primary
malignancy. ④ CRN without neurologic symptoms or signs. ⑤ CRN combined with diabetes.
⑥CRN patients that were supposed to live less than 6 months.
Type of Study:
Observational [Patient Registry]
Observational Model: Cohort, Time Perspective: Prospective
The necrotic volume showed on MRI
Outcome Time Frame:
ChaoSu Hu, MD, PhD
Shanghai Cancer Center, Fudan University
China: Science and Technology Commission of Shanghai Municipality
- Nasopharyngeal Carcinoma
- Cerebral Radiation Necrosis
- Nasopharyngeal Neoplasms